11.15.19
5 min. Read

Google-Ascension recap. Deals, clearances, studies.

Issue 028. Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had an encouraging 64 percent open rate. Here's what's happening this week:

  • This issue's intro section is dedicated to the snowballing Google-Ascension story, which first got rolling with a breathless report in The Wall Street Journal over what seemed at first blush to be a not-terribly-uncommon BAA health data deal.
  • After the story hit, the HHS Office of Civil Rights announced an investigation into the deal to determine if they've followed the letter of HIPAA. Congressional members quickly called for a hearing broader in scope that would look into whether Big Tech companies were complying with HIPAA. The hullabaloo also reignited calls for a new law that would govern how health-related data not covered by HIPAA could be shared or purchased, including data from

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Mahana Therapeutics’ insolvency. FDA clears Happy Ring (Tinder founder’s smart ring)
10.04.24
6 min. Read
Flashback: How Proteus Digital Health’s outcomes-based pricing worked for Tennessee Medicaid
9.20.24
5 min. Read
Are the Digital Mental Health Treatment G Codes necessary? Or RTM dupes?
7.12.24
7 min. Read
Which PDTs are still around? New bill in Congress.
6.28.24
10 min. Read
FDA OKs Alivecor (12L?), Akili OTC. Oui eyes obesity.
6.21.24
5 min. Read
Digging into the Akili-Virtual Therapeutics deal
5.31.24
10 min. Read
CMS questions MedRhythms on InTandem
5.17.24
5 min. Read
MedRhythms-Alexion. Akili RCT for OTC.
4.26.24
6 min. Read
Hints about Otsuka’s commercialization plan for Rejoyn
4.16.24
6 min. Read
Better Therapeutics shuts down. Mahana-Cara Care
3.15.24
5 min. Read
  • First
  • Previous
  • 1 of 21
  • Next
  • Last